Hendrix, Philipp
Melamed, Itay
Collins, Malie
Lieberman, Noah
Sharma, Vaibhav
Goren, Oded
Zand, Ramin
Schirmer, Clemens M.
Griessenauer, Christoph J.
Funding for this research was provided by:
Geisinger and Medtronic
Article History
Received: 21 May 2021
Accepted: 12 July 2021
First Online: 17 August 2021
Declarations
:
: The authors P. Hendrix, I. Melamed, M. Collins, N. Lieberman, V. Sharma, O. Goren, R. Zand, C.M. Schirmer and C.J. Griessenauer have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article. Outside the presented work: OG received consulting fees from Stryker; CMS received research funding from Penumbra and has ownership in NTI; CG received research funding from Medtronic and Penumbra, and consulting fees from Stryker and MicroVention.
: This retrospective study was performed after consultation with the institutional ethics committee and in accordance with national legal requirements. IRB approval for this retrospective analysis was obtained.